New Zealand’s pancreatic cancer survival rate below comparable countries – study
The study, published in The Lancet Oncology journal on Wednesday, analysed 3.9 million cancer cases from New Zealand, Australia, Canada, Denmark, the UK, Ireland…
Risk, phenotypes, therapeutics and resistance
Here are some of advances in molecular oncology you may have missed during your summer vacation. Read more . .…
Bacteria in Pancreatic Tumors Impact Immune Response and Survival, Study Examines Potential for Modulation
When the investigators conducted a mouse model study of fecal microbiota transplants (FMT) from patients, they found that the mice…
Overcoming Resistance in Pancreatic Cancer
A group of researchers at Cold Spring Harbor Laboratory (CSHL) has now found a way to tackle this problem and…
DPP-4 Inhibitors Linked to Risk for Pancreatitis, Pancreatic Cancer
DPP-4is are incretin-based agents known to have effects on pancreatic function. Researchers aimed to investigate the risk for pancreatitis and…
Metastatic Pancreas Cancer; Sequencing Therapies
Panelists: Edward Kim, MD, University of California Davis; John Marshall, MD, Georgetown University Lombardi Comprehensive Cancer Center; Paul Oberstein, MD,…
